Programmed cell death-1 inhibitor combination treatment for recurrent proficient mismatch repair/ miscrosatellite-stable type endometrial cancer: A case report

BACKGROUND: Endometrial cancer (EC) is one of the most common cancers of the female reproductive tract, and the incidence is increasing rapidly. Immunotherapy using programmed cell death-1 (PD-1) inhibitors is an emerging research topic and treatment strategy for refractory gynecological malignancie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Chong-Ya, Yin, Lu-Xi, Han, Wei-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353916/
https://www.ncbi.nlm.nih.gov/pubmed/36157989
http://dx.doi.org/10.12998/wjcc.v10.i21.7474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353916/
https://www.ncbi.nlm.nih.gov/pubmed/36157989
http://dx.doi.org/10.12998/wjcc.v10.i21.7474

Ejemplares similares